Differences in syncytia formation by SARS-CoV-2 variants modify host chromatin accessibility and cellular senescence via TP53
Authors:
Preprint
Abstract
COVID-19 remains a significant public health threat due to the ability of SARS-CoV-2 variants to evade the immune system and cause breakthrough infections. Although pathogenic coronaviruses such as SARS-CoV-2 and MERS-CoV lead to severe respiratory infections, how these viruses affect the chromatin proteomic composition upon infection remains largely uncharacterized. Here we used our recently developed integrative DNA And Protein Tagging (iDAPT) methodology to identify changes in host chromatin accessibility states and chromatin proteomic composition upon infection with pathogenic coronaviruses. SARS-CoV-2 infection induces TP53 stabilization on chromatin, which contributes to its host cytopathic effect. We mapped this TP53 stabilization to the SARS-CoV-2 spike and its propensity to form syncytia, a consequence of cell-cell fusion. Differences in SARS-CoV-2 spike variant-induced syncytia formation modify chromatin accessibility, cellular senescence, and inflammatory cytokine release via TP53. Our findings suggest that differences in syncytia formation alter senescence-associated inflammation, which varies among SARS-CoV-2 variants.Keywords
All Related Versions
- Published version: Cell Reports, 42 (12), 113478.
This publication has 150 references indexed in Scilit:
- SARS-CoV-2 triggers DNA damage response in Vero E6 cellsBiochemical and Biophysical Research Communications, 2021
- Isobaric Tag‐Based Protein Profiling of a Nicotine‐Treated Alpha7 Nicotinic Receptor‐Null Human Haploid Cell LineProteomics, 2018
- Senescence in Health and DiseaseCell, 2017
- A Triple Knockout (TKO) Proteomics Standard for Diagnosing Ion Interference in Isobaric Labeling ExperimentsJournal of the American Society for Mass Spectrometry, 2016
- Determination and Inference of Eukaryotic Transcription Factor Sequence SpecificityCell, 2014
- Genome guardian p53 and viral infectionsReviews in Medical Virology, 2012
- Reversed‐phase chromatography with multiple fraction concatenation strategy for proteome profiling of human MCF10A cellsProteomics, 2011
- A Tissue-Specific Atlas of Mouse Protein Phosphorylation and ExpressionCell, 2010
- Target-Decoy Search Strategy for Mass Spectrometry-Based Proteomics2009
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993